Viewing Study NCT02414269


Ignite Creation Date: 2025-12-24 @ 11:05 PM
Ignite Modification Date: 2026-02-22 @ 7:25 AM
Study NCT ID: NCT02414269
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-08
First Post: 2015-04-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module